Canton Strategic Holdings (CNTN) Retained Earnings (2020 - 2026)
Canton Strategic Holdings (CNTN) posted Retained Earnings of $590.0 million for Q1 2026, up 910.28% on a QoQ basis from -$72.8 million in Q4 2025, and up 1597.52% year-over-year from $34.8 million in Q1 2025.
Canton Strategic Holdings (CNTN) Retained Earnings (2020 - 2026) Analysis & Trends
Canton Strategic Holdings' Retained Earnings history runs 7 years deep, the most recent figure standing at $590.0 million for Q1 2026.
- Quarterly Retained Earnings rose 1597.52% year-over-year to $590.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $590.0 million (up 1597.52% YoY) and the FY2025 annual result came in at -$72.8 million, down 290.23% from the prior year.
- Retained Earnings was $590.0 million for Q1 2026 at Canton Strategic Holdings, up from -$72.8 million in the prior quarter.
- Across five years, Retained Earnings topped out at $590.0 million in Q1 2026 and bottomed at -$72.8 million in Q4 2025.
- A 5-year average of $32.1 million and a median of -$9.9 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 791.21% — and 2026, when it jumped 1597.52%.
- Canton Strategic Holdings' Retained Earnings stood at -$15.4 million in 2022, then plunged by 60.57% to -$24.7 million in 2023, then soared by 254.95% to $38.3 million in 2024, then plunged by 290.23% to -$72.8 million in 2025, then jumped by 910.28% to $590.0 million in 2026.
- Business Quant data shows CNTN's Retained Earnings at $590.0 million in Q1 2026, -$72.8 million in Q4 2025, and -$43.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Canton Strategic Holdings | 427.87 Mn | 427.87 Mn | - | 590.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 590.02 Mn |
| Dec 31, 2025 | -72.82 Mn |
| Sep 30, 2025 | -43.40 Mn |
| Jun 30, 2025 | 41.73 Mn |
| Mar 31, 2025 | -39.40 Mn |
| Dec 31, 2024 | 38.28 Mn |
| Sep 30, 2024 | 36.17 Mn |
| Jun 30, 2024 | 36.05 Mn |
| Mar 31, 2024 | -27.00 Mn |
| Dec 31, 2023 | -24.70 Mn |
| Sep 30, 2023 | 24.05 Mn |
| Jun 30, 2023 | 23.55 Mn |
| Mar 31, 2023 | -18.10 Mn |
| Dec 31, 2022 | -15.38 Mn |
| Sep 30, 2022 | -13.62 Mn |
| Jun 30, 2022 | 20.55 Mn |
| Mar 31, 2022 | -9.85 Mn |
| Dec 31, 2021 | 2.23 Mn |
| Dec 31, 2020 | 986,443.00 |